Biosolutions

Biosolutions

The pace that society produces and releases chemicals and other novel entities into the environment is not consistent with staying within a safe operating space for humanity. We invest in cutting edge biotechnology generating new materials that can replace key drivers of pollution and emissions.

We invest in new materials that can replace key drivers of pollution and emissions

Many of today’s materials and chemicals are incompatible with planetary boundaries. Biosolutions offer cleaner, nature-based alternatives.

Our investment thesis

We invest in the tools of nature to deliver novel bio-based materials and processes that replace fossil-based and highly polluting inputs across industries, while remaining commercially competitive.

What we are looking for
  • Cutting edge biotech enabling greener solutions that were not possible yesterday
  • Solutions with potential to scale and generate significant impact at cost parity with existing solutions
  • Technologies ready to scale into existing value chains

Our investments within biosolutions

We have invested in solutions that are cutting emissions, protecting biodiversity, and proving that biology is one of the most powerful technologies we have for building a future worth venturing into.

“Biosolutions allow us to redesign materials from the molecule up – with nature as the blueprint.”

Explore all our investment verticals

  • Our current linear ‘take-make-waste’ system use 60% more resources than the earth can generate every year. We invest in solutions that enable reuse, upcycling and recycling of waste streams to enable a circular economy.

    image-b453cd1d89cbfdd7c06fb13a7e8f66112cca5680-6000x4000-jpg
Sofie Kall

Come venture with us

Pitch usabout mailto:pitch@thefootprintfirm.com

Pitch us

Have a venture where impact and growth scale together? We invest early and work side-by-side powered by the whole Footprint Firm team.

Pitch us about mailto:pitch@thefootprintfirm.com

Sofie brings a decade of experience in investment, corporate finance, and strategy. Having worked across private equity, growth capital, and venture capital, she has been deeply involved in investments, advisory boards, and sustainability initiatives. Before joining us, Sofie was part of the investment team at SEB Private Equity, where she was responsible for investing capital from top tier, third party institutions into private equity on a global scale in different structures. Sofie worked as a sparring partner, serving on the advisory board of top tier private equity firms and led numerous co-investments spanning private equity, growth capital and venture capital.

In the Nordics, Sofie led the acquisition and divestment of majority and significant minority investments and served on the board of companies like Planday, VaccinDirekt and Better Jusage. Additionally, her experience includes running mandates and raising external funds, as well as being a driver of the sustainability strategy and serving on the ESG Committee.

Academically, Sofie holds an MSc in Corporate Finance from Cass Business School (now Bayes Business School) in London and a BSc in Business Administration from Lund University (including a secondment at the University of Melbourne).